查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1947918

生命科学工具市场分析及预测（至2035年）：依类型、产品、服务、技术、组件、应用、最终用户、功能及设备划分

Life Science Tools Market Analysis and Forecast to 2035: Type, Product, Services, Technology, Component, Application, End User, Functionality, Equipment
出版日期: | 出版商: Global Insight Services | 英文 368 Pages | 商品交期: 3-5个工作天内

价格
简介目录

生命科学工具市场预计将从2024年的957亿美元成长到2034年的1,702亿美元，复合年增长率约为6.2%。生命科学工具市场涵盖了生物技术、製药和医疗保健领域研发所需的各种设备、耗材和服务。该市场支持基因测序、蛋白质组学和细胞生物学研究，从而推动药物发现和个人化医疗的发展。在技​​术创新和研发投入不断增长的驱动下，该行业正蓬勃发展，并日益注重精准性、自动化和数据整合，以提昇科研成果和治疗方案。

生命科学工具市场正经历强劲成长，这得益于生物技术的进步和日益活跃的研究活动。基因组学领域已成为成长最快的细分市场，这主要得益于次世代定序技术和个人化医疗的广泛应用。蛋白质体学是成长第二快的细分市场，其成长动力来自质谱和蛋白质分析技术的进步。在基因组学领域，定序技术子领域由于高通量和低成本定序方法的创新而发挥主导作用。生物资讯工具是支援资料分析和解读的关键组成部分。在蛋白质体学领域，质谱仪子领域对于增强蛋白质表征和生物标记发现至关重要。实验室设备的自动化和小型化正在加速发展，提高了效率和通量。人工智慧（AI）和机器学习与生命科学工具的融合有望彻底改变资料分析和预测建模。策略联盟和研发投入正在推动创新，为这个充满活力的市场中的相关人员提供了盈利的机会。

市场区隔
类型 设备、试剂、耗材、软体
产品 定序平台、PCR仪、质谱仪、流式细胞仪、层析法系统、显微镜、细胞计数器
服务 基因组学服务、蛋白质组学服务、生物资讯服务、细胞分析服务
科技 基因组学、蛋白质组学、代谢体学、表观基因
成分 硬体和软体
目的 药物发现、临床诊断、研究应用、生物技术
最终用户 製药公司、生技公司、学术研究机构、受託研究机构
功能 自动、手动、半自动
装置 实验室和分析设备

生命科学工具市场的特征是市占率分布动态变化、定价策略复杂、创新产品层出不穷。主要企业不断拓展产品组合，专注于最尖端科技技术以提升其科学研究能力。价格竞争持续不断，各企业正利用规模经济和策略联盟来维持市场地位。新产品频繁推出，反映了技术进步的迅猛步伐以及产业致力于满足不断变化的科研需求。竞争基准分析显示，主要企业之间竞争激烈，它们竞相争夺技术优势和市场主导地位。监理政策影响显着，严格的合规要求塑造企业的策略。北美和欧洲的政策制定了品质和安全标准，对市场产生重大影响。由于有利的法规环境和不断完善的科学研究基础设施，亚太地区的新兴市场正吸引越来越多的投资。竞争格局的特点是策略联盟、併购，旨在巩固市场地位并促进创新。

主要趋势和驱动因素：

生命科学工具市场正经历强劲成长，这主要得益于技术进步和日益活跃的研究活动。关键趋势包括人工智慧 (AI) 和机器学习的融合，这使得数据分析更加复杂，研究成果也得以更快地产出。个人化医疗的兴起推动了对先进诊断工具的需求，以实现精准的个人化患者照护。次世代定序技术的出现正在革新基因组学，使其更易于获取且更具成本效益，从而促进药物发现和开发的创新。此外，慢性病发病率的上升也推动了对先进分析设备和试剂的需求，以支持全面的研究和临床诊断。公营和私营部门对研发的大量投入是推动市场成长的重要因素。各国政府对医疗进步的重视进一步刺激了市场成长。新兴市场医疗基础设施的快速发展蕴藏着许多机会。提供创新且价格合理的解决方案的公司有望占据可观的市场份额。生命科学工具的持续发展有望为医疗保健和生物技术产业带来持续成长和变革性影响。

目录

第一章执行摘要

第二章 市集亮点

第三章 市场动态

  • 宏观经济分析
  • 市场趋势
  • 市场驱动因素
  • 市场机会
  • 市场限制
  • 复合年均成长率：成长分析
  • 影响分析
  • 新兴市场
  • 技术蓝图
  • 战略框架

第四章 细分市场分析

  • 市场规模及预测：依类型
    • 装置
    • 试剂
    • 消耗品
    • 软体
  • 市场规模及预测：依产品划分
    • 定序平台
    • PCR装置
    • 质谱仪
    • 流式细胞仪
    • 层析法系统
    • 显微镜
    • 细胞计数器
  • 市场规模及预测：依服务划分
    • 基因组学服务
    • 蛋白质体学服务
    • 生物资讯服务
    • 细胞分析服务
  • 市场规模及预测：依技术划分
    • 基因组学
    • 蛋白质体学
    • 代谢体学
    • 表观基因
  • 市场规模及预测：依组件划分
    • 硬体
    • 软体
  • 市场规模及预测：依应用领域划分
    • 药物发现
    • 临床诊断
    • 研究用途
    • 生物技术
  • 市场规模及预测：依最终用户划分
    • 製药公司
    • 生技公司
    • 学术研究机构
    • 受託研究机构
  • 市场规模及预测：依功能划分
    • 自动的
    • 手动的
    • 半自动
  • 市场规模及预测：依设备划分
    • 实验室设备
    • 分析设备

第五章 区域分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 拉丁美洲
    • 巴西
    • 阿根廷
    • 其他拉丁美洲地区
  • 亚太地区
    • 中国
    • 印度
    • 韩国
    • 日本
    • 澳洲
    • 台湾
    • 亚太其他地区
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 西班牙
    • 义大利
    • 其他欧洲地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 撒哈拉以南非洲
    • 其他中东和非洲地区

第六章 市场策略

  • 需求与供给差距分析
  • 贸易和物流限制
  • 价格、成本和利润率趋势
  • 市场渗透率
  • 消费者分析
  • 法规概述

第七章 竞争讯息

  • 市场定位
  • 市场占有率
  • 竞争基准
  • 主要企业的策略

第八章：公司简介

  • Bio-Rad Laboratories
  • Perkin Elmer
  • Agilent Technologies
  • Illumina
  • Meridian Bioscience
  • QIAGEN
  • Bruker
  • Waters Corporation
  • Sartorius
  • Tecan Group
  • Oxford Instruments
  • Shimadzu Corporation
  • Horiba
  • Bio-Techne
  • Charles River Laboratories
  • Eurofins Scientific
  • Luminex Corporation
  • Fluidigm
  • Abcam
  • Promega Corporation

第九章：关于我们

简介目录
Product Code: GIS21114

Life Science Tools Market is anticipated to expand from $95.7 billion in 2024 to $170.2 billion by 2034, growing at a CAGR of approximately 6.2%. The Life Science Tools Market encompasses a broad range of instruments, consumables, and services essential for research and development in biotechnology, pharmaceuticals, and healthcare. This market supports genomic sequencing, proteomics, and cell biology, facilitating advancements in drug discovery and personalized medicine. Driven by technological innovations and increased R&D spending, the sector is poised for growth, emphasizing precision, automation, and data integration to enhance scientific outcomes and therapeutic solutions.

The Life Science Tools Market is experiencing robust expansion due to advancements in biotechnology and increased research activities. The genomics segment emerges as the top-performing sector, driven by the proliferation of next-generation sequencing technologies and personalized medicine. Proteomics follows as the second highest-performing segment, fueled by advancements in mass spectrometry and protein analysis techniques. Within genomics, the sub-segment of sequencing technologies is leading, with innovations in high-throughput and cost-effective sequencing methods. Bioinformatics tools are critical, supporting data analysis and interpretation. In proteomics, the sub-segment of mass spectrometry instruments is pivotal, enhancing protein characterization and biomarker discovery. Automation and miniaturization in laboratory instruments are gaining momentum, improving efficiency and throughput. The integration of artificial intelligence and machine learning in life science tools is poised to revolutionize data analysis and predictive modeling. Strategic collaborations and investments in R&D are driving innovation, presenting lucrative opportunities for stakeholders in this dynamic market.

Market Segmentation
TypeInstruments, Reagents, Consumables, Software
ProductSequencing Platforms, PCR Instruments, Mass Spectrometers, Flow Cytometers, Chromatography Systems, Microscopes, Cell Counters
ServicesGenomics Services, Proteomics Services, Bioinformatics Services, Cell Analysis Services
TechnologyGenomics, Proteomics, Metabolomics, Epigenomics
ComponentHardware, Software
ApplicationDrug Discovery, Clinical Diagnostics, Research Applications, Biotechnology
End UserPharmaceutical Companies, Biotechnology Companies, Academic Research Institutes, Contract Research Organizations
FunctionalityAutomated, Manual, Semi-automated
EquipmentLaboratory Equipment, Analytical Equipment

The Life Science Tools Market is characterized by a dynamic landscape of market share distribution, pricing strategies, and innovative product launches. Key players are consistently expanding their portfolios, focusing on cutting-edge technologies to enhance research capabilities. Pricing remains competitive, with companies leveraging economies of scale and strategic partnerships to maintain market presence. New product launches are frequent, reflecting the rapid pace of technological advancements and the industry's commitment to addressing evolving scientific needs. Competition benchmarking reveals a robust rivalry among leading firms, each vying for technological superiority and market dominance. Regulatory influences are significant, with stringent compliance requirements shaping operational strategies. The market is heavily influenced by policies in North America and Europe, which set the standards for quality and safety. Emerging markets in Asia-Pacific are witnessing increased investment, driven by favorable regulatory environments and growing research infrastructure. The competitive landscape is marked by strategic collaborations, mergers, and acquisitions, aimed at consolidating market positions and fostering innovation.

Geographical Overview:

The life science tools market is witnessing robust growth across various regions, each presenting unique opportunities. North America remains at the forefront, driven by substantial investments in research and development. The presence of leading biotech companies and advanced healthcare infrastructure further propels market expansion. Europe follows, with a strong focus on innovation and regulatory support enhancing the market landscape. The region's emphasis on precision medicine and genomics accelerates growth. In Asia Pacific, the market is rapidly expanding, fueled by increasing healthcare expenditure and technological advancements. Countries like China and India are emerging as significant players, offering lucrative opportunities due to their large populations and growing biopharmaceutical sectors. Latin America and the Middle East & Africa are also witnessing promising growth. Brazil and South Africa are emerging as key markets, with rising investments in healthcare infrastructure and research initiatives driving demand for life science tools.

The Life Science Tools Market is significantly influenced by global tariffs, geopolitical tensions, and evolving supply chain dynamics. In Japan and South Korea, trade tensions with China have prompted increased investment in domestic biotech innovation and collaboration with Western firms to mitigate risks. China, facing tariffs and export restrictions, is accelerating its focus on self-sufficiency in life science technologies, while Taiwan remains a pivotal player in biotech manufacturing, albeit vulnerable to geopolitical strife. The global parent market is robust, driven by innovation and demand for precision medicine. By 2035, the market is poised for substantial growth, contingent on resilient supply chains and strategic alliances. Middle East conflicts could exacerbate global supply chain challenges and elevate energy costs, impacting production and distribution efficiencies.

Key Trends and Drivers:

The life science tools market is experiencing robust growth fueled by technological advancements and increased research activities. Key trends include the integration of artificial intelligence and machine learning, which enhance data analysis and accelerate research outcomes. The rise of personalized medicine is driving demand for advanced diagnostic tools, enabling precise and individualized patient care. The advent of next-generation sequencing technologies is revolutionizing genomics, making it more accessible and cost-effective. This is fostering innovation in drug discovery and development. Furthermore, the increasing prevalence of chronic diseases is propelling the need for sophisticated analytical instruments and reagents, supporting comprehensive research and clinical diagnostics. Drivers include substantial investments in research and development by both public and private sectors. Governments are prioritizing healthcare advancements, further stimulating market growth. Opportunities abound in emerging markets where healthcare infrastructure is expanding rapidly. Companies that offer innovative and affordable solutions are poised to capture significant market share. The continuous evolution of life science tools promises sustained growth and transformative impacts on healthcare and biotechnology industries.

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

  • 1.1 Market Size and Forecast
  • 1.2 Market Overview
  • 1.3 Market Snapshot
  • 1.4 Regional Snapshot
  • 1.5 Strategic Recommendations
  • 1.6 Analyst Notes

2 Market Highlights

  • 2.1 Key Market Highlights by Type
  • 2.2 Key Market Highlights by Product
  • 2.3 Key Market Highlights by Services
  • 2.4 Key Market Highlights by Technology
  • 2.5 Key Market Highlights by Component
  • 2.6 Key Market Highlights by Application
  • 2.7 Key Market Highlights by End User
  • 2.8 Key Market Highlights by Functionality
  • 2.9 Key Market Highlights by Equipment

3 Market Dynamics

  • 3.1 Macroeconomic Analysis
  • 3.2 Market Trends
  • 3.3 Market Drivers
  • 3.4 Market Opportunities
  • 3.5 Market Restraints
  • 3.6 CAGR Growth Analysis
  • 3.7 Impact Analysis
  • 3.8 Emerging Markets
  • 3.9 Technology Roadmap
  • 3.10 Strategic Frameworks
    • 3.10.1 PORTER's 5 Forces Model
    • 3.10.2 ANSOFF Matrix
    • 3.10.3 4P's Model
    • 3.10.4 PESTEL Analysis

4 Segment Analysis

  • 4.1 Market Size & Forecast by Type (2020-2035)
    • 4.1.1 Instruments
    • 4.1.2 Reagents
    • 4.1.3 Consumables
    • 4.1.4 Software
  • 4.2 Market Size & Forecast by Product (2020-2035)
    • 4.2.1 Sequencing Platforms
    • 4.2.2 PCR Instruments
    • 4.2.3 Mass Spectrometers
    • 4.2.4 Flow Cytometers
    • 4.2.5 Chromatography Systems
    • 4.2.6 Microscopes
    • 4.2.7 Cell Counters
  • 4.3 Market Size & Forecast by Services (2020-2035)
    • 4.3.1 Genomics Services
    • 4.3.2 Proteomics Services
    • 4.3.3 Bioinformatics Services
    • 4.3.4 Cell Analysis Services
  • 4.4 Market Size & Forecast by Technology (2020-2035)
    • 4.4.1 Genomics
    • 4.4.2 Proteomics
    • 4.4.3 Metabolomics
    • 4.4.4 Epigenomics
  • 4.5 Market Size & Forecast by Component (2020-2035)
    • 4.5.1 Hardware
    • 4.5.2 Software
  • 4.6 Market Size & Forecast by Application (2020-2035)
    • 4.6.1 Drug Discovery
    • 4.6.2 Clinical Diagnostics
    • 4.6.3 Research Applications
    • 4.6.4 Biotechnology
  • 4.7 Market Size & Forecast by End User (2020-2035)
    • 4.7.1 Pharmaceutical Companies
    • 4.7.2 Biotechnology Companies
    • 4.7.3 Academic Research Institutes
    • 4.7.4 Contract Research Organizations
  • 4.8 Market Size & Forecast by Functionality (2020-2035)
    • 4.8.1 Automated
    • 4.8.2 Manual
    • 4.8.3 Semi-automated
  • 4.9 Market Size & Forecast by Equipment (2020-2035)
    • 4.9.1 Laboratory Equipment
    • 4.9.2 Analytical Equipment

5 Regional Analysis

  • 5.1 Global Market Overview
  • 5.2 North America Market Size (2020-2035)
    • 5.2.1 United States
      • 5.2.1.1 Type
      • 5.2.1.2 Product
      • 5.2.1.3 Services
      • 5.2.1.4 Technology
      • 5.2.1.5 Component
      • 5.2.1.6 Application
      • 5.2.1.7 End User
      • 5.2.1.8 Functionality
      • 5.2.1.9 Equipment
    • 5.2.2 Canada
      • 5.2.2.1 Type
      • 5.2.2.2 Product
      • 5.2.2.3 Services
      • 5.2.2.4 Technology
      • 5.2.2.5 Component
      • 5.2.2.6 Application
      • 5.2.2.7 End User
      • 5.2.2.8 Functionality
      • 5.2.2.9 Equipment
    • 5.2.3 Mexico
      • 5.2.3.1 Type
      • 5.2.3.2 Product
      • 5.2.3.3 Services
      • 5.2.3.4 Technology
      • 5.2.3.5 Component
      • 5.2.3.6 Application
      • 5.2.3.7 End User
      • 5.2.3.8 Functionality
      • 5.2.3.9 Equipment
  • 5.3 Latin America Market Size (2020-2035)
    • 5.3.1 Brazil
      • 5.3.1.1 Type
      • 5.3.1.2 Product
      • 5.3.1.3 Services
      • 5.3.1.4 Technology
      • 5.3.1.5 Component
      • 5.3.1.6 Application
      • 5.3.1.7 End User
      • 5.3.1.8 Functionality
      • 5.3.1.9 Equipment
    • 5.3.2 Argentina
      • 5.3.2.1 Type
      • 5.3.2.2 Product
      • 5.3.2.3 Services
      • 5.3.2.4 Technology
      • 5.3.2.5 Component
      • 5.3.2.6 Application
      • 5.3.2.7 End User
      • 5.3.2.8 Functionality
      • 5.3.2.9 Equipment
    • 5.3.3 Rest of Latin America
      • 5.3.3.1 Type
      • 5.3.3.2 Product
      • 5.3.3.3 Services
      • 5.3.3.4 Technology
      • 5.3.3.5 Component
      • 5.3.3.6 Application
      • 5.3.3.7 End User
      • 5.3.3.8 Functionality
      • 5.3.3.9 Equipment
  • 5.4 Asia-Pacific Market Size (2020-2035)
    • 5.4.1 China
      • 5.4.1.1 Type
      • 5.4.1.2 Product
      • 5.4.1.3 Services
      • 5.4.1.4 Technology
      • 5.4.1.5 Component
      • 5.4.1.6 Application
      • 5.4.1.7 End User
      • 5.4.1.8 Functionality
      • 5.4.1.9 Equipment
    • 5.4.2 India
      • 5.4.2.1 Type
      • 5.4.2.2 Product
      • 5.4.2.3 Services
      • 5.4.2.4 Technology
      • 5.4.2.5 Component
      • 5.4.2.6 Application
      • 5.4.2.7 End User
      • 5.4.2.8 Functionality
      • 5.4.2.9 Equipment
    • 5.4.3 South Korea
      • 5.4.3.1 Type
      • 5.4.3.2 Product
      • 5.4.3.3 Services
      • 5.4.3.4 Technology
      • 5.4.3.5 Component
      • 5.4.3.6 Application
      • 5.4.3.7 End User
      • 5.4.3.8 Functionality
      • 5.4.3.9 Equipment
    • 5.4.4 Japan
      • 5.4.4.1 Type
      • 5.4.4.2 Product
      • 5.4.4.3 Services
      • 5.4.4.4 Technology
      • 5.4.4.5 Component
      • 5.4.4.6 Application
      • 5.4.4.7 End User
      • 5.4.4.8 Functionality
      • 5.4.4.9 Equipment
    • 5.4.5 Australia
      • 5.4.5.1 Type
      • 5.4.5.2 Product
      • 5.4.5.3 Services
      • 5.4.5.4 Technology
      • 5.4.5.5 Component
      • 5.4.5.6 Application
      • 5.4.5.7 End User
      • 5.4.5.8 Functionality
      • 5.4.5.9 Equipment
    • 5.4.6 Taiwan
      • 5.4.6.1 Type
      • 5.4.6.2 Product
      • 5.4.6.3 Services
      • 5.4.6.4 Technology
      • 5.4.6.5 Component
      • 5.4.6.6 Application
      • 5.4.6.7 End User
      • 5.4.6.8 Functionality
      • 5.4.6.9 Equipment
    • 5.4.7 Rest of APAC
      • 5.4.7.1 Type
      • 5.4.7.2 Product
      • 5.4.7.3 Services
      • 5.4.7.4 Technology
      • 5.4.7.5 Component
      • 5.4.7.6 Application
      • 5.4.7.7 End User
      • 5.4.7.8 Functionality
      • 5.4.7.9 Equipment
  • 5.5 Europe Market Size (2020-2035)
    • 5.5.1 Germany
      • 5.5.1.1 Type
      • 5.5.1.2 Product
      • 5.5.1.3 Services
      • 5.5.1.4 Technology
      • 5.5.1.5 Component
      • 5.5.1.6 Application
      • 5.5.1.7 End User
      • 5.5.1.8 Functionality
      • 5.5.1.9 Equipment
    • 5.5.2 France
      • 5.5.2.1 Type
      • 5.5.2.2 Product
      • 5.5.2.3 Services
      • 5.5.2.4 Technology
      • 5.5.2.5 Component
      • 5.5.2.6 Application
      • 5.5.2.7 End User
      • 5.5.2.8 Functionality
      • 5.5.2.9 Equipment
    • 5.5.3 United Kingdom
      • 5.5.3.1 Type
      • 5.5.3.2 Product
      • 5.5.3.3 Services
      • 5.5.3.4 Technology
      • 5.5.3.5 Component
      • 5.5.3.6 Application
      • 5.5.3.7 End User
      • 5.5.3.8 Functionality
      • 5.5.3.9 Equipment
    • 5.5.4 Spain
      • 5.5.4.1 Type
      • 5.5.4.2 Product
      • 5.5.4.3 Services
      • 5.5.4.4 Technology
      • 5.5.4.5 Component
      • 5.5.4.6 Application
      • 5.5.4.7 End User
      • 5.5.4.8 Functionality
      • 5.5.4.9 Equipment
    • 5.5.5 Italy
      • 5.5.5.1 Type
      • 5.5.5.2 Product
      • 5.5.5.3 Services
      • 5.5.5.4 Technology
      • 5.5.5.5 Component
      • 5.5.5.6 Application
      • 5.5.5.7 End User
      • 5.5.5.8 Functionality
      • 5.5.5.9 Equipment
    • 5.5.6 Rest of Europe
      • 5.5.6.1 Type
      • 5.5.6.2 Product
      • 5.5.6.3 Services
      • 5.5.6.4 Technology
      • 5.5.6.5 Component
      • 5.5.6.6 Application
      • 5.5.6.7 End User
      • 5.5.6.8 Functionality
      • 5.5.6.9 Equipment
  • 5.6 Middle East & Africa Market Size (2020-2035)
    • 5.6.1 Saudi Arabia
      • 5.6.1.1 Type
      • 5.6.1.2 Product
      • 5.6.1.3 Services
      • 5.6.1.4 Technology
      • 5.6.1.5 Component
      • 5.6.1.6 Application
      • 5.6.1.7 End User
      • 5.6.1.8 Functionality
      • 5.6.1.9 Equipment
    • 5.6.2 United Arab Emirates
      • 5.6.2.1 Type
      • 5.6.2.2 Product
      • 5.6.2.3 Services
      • 5.6.2.4 Technology
      • 5.6.2.5 Component
      • 5.6.2.6 Application
      • 5.6.2.7 End User
      • 5.6.2.8 Functionality
      • 5.6.2.9 Equipment
    • 5.6.3 South Africa
      • 5.6.3.1 Type
      • 5.6.3.2 Product
      • 5.6.3.3 Services
      • 5.6.3.4 Technology
      • 5.6.3.5 Component
      • 5.6.3.6 Application
      • 5.6.3.7 End User
      • 5.6.3.8 Functionality
      • 5.6.3.9 Equipment
    • 5.6.4 Sub-Saharan Africa
      • 5.6.4.1 Type
      • 5.6.4.2 Product
      • 5.6.4.3 Services
      • 5.6.4.4 Technology
      • 5.6.4.5 Component
      • 5.6.4.6 Application
      • 5.6.4.7 End User
      • 5.6.4.8 Functionality
      • 5.6.4.9 Equipment
    • 5.6.5 Rest of MEA
      • 5.6.5.1 Type
      • 5.6.5.2 Product
      • 5.6.5.3 Services
      • 5.6.5.4 Technology
      • 5.6.5.5 Component
      • 5.6.5.6 Application
      • 5.6.5.7 End User
      • 5.6.5.8 Functionality
      • 5.6.5.9 Equipment

6 Market Strategy

  • 6.1 Demand-Supply Gap Analysis
  • 6.2 Trade & Logistics Constraints
  • 6.3 Price-Cost-Margin Trends
  • 6.4 Market Penetration
  • 6.5 Consumer Analysis
  • 6.6 Regulatory Snapshot

7 Competitive Intelligence

  • 7.1 Market Positioning
  • 7.2 Market Share
  • 7.3 Competition Benchmarking
  • 7.4 Top Company Strategies

8 Company Profiles

  • 8.1 Bio- Rad Laboratories
    • 8.1.1 Overview
    • 8.1.2 Product Summary
    • 8.1.3 Financial Performance
    • 8.1.4 SWOT Analysis
  • 8.2 Perkin Elmer
    • 8.2.1 Overview
    • 8.2.2 Product Summary
    • 8.2.3 Financial Performance
    • 8.2.4 SWOT Analysis
  • 8.3 Agilent Technologies
    • 8.3.1 Overview
    • 8.3.2 Product Summary
    • 8.3.3 Financial Performance
    • 8.3.4 SWOT Analysis
  • 8.4 Illumina
    • 8.4.1 Overview
    • 8.4.2 Product Summary
    • 8.4.3 Financial Performance
    • 8.4.4 SWOT Analysis
  • 8.5 Meridian Bioscience
    • 8.5.1 Overview
    • 8.5.2 Product Summary
    • 8.5.3 Financial Performance
    • 8.5.4 SWOT Analysis
  • 8.6 QIAGEN
    • 8.6.1 Overview
    • 8.6.2 Product Summary
    • 8.6.3 Financial Performance
    • 8.6.4 SWOT Analysis
  • 8.7 Bruker
    • 8.7.1 Overview
    • 8.7.2 Product Summary
    • 8.7.3 Financial Performance
    • 8.7.4 SWOT Analysis
  • 8.8 Waters Corporation
    • 8.8.1 Overview
    • 8.8.2 Product Summary
    • 8.8.3 Financial Performance
    • 8.8.4 SWOT Analysis
  • 8.9 Sartorius
    • 8.9.1 Overview
    • 8.9.2 Product Summary
    • 8.9.3 Financial Performance
    • 8.9.4 SWOT Analysis
  • 8.10 Tecan Group
    • 8.10.1 Overview
    • 8.10.2 Product Summary
    • 8.10.3 Financial Performance
    • 8.10.4 SWOT Analysis
  • 8.11 Oxford Instruments
    • 8.11.1 Overview
    • 8.11.2 Product Summary
    • 8.11.3 Financial Performance
    • 8.11.4 SWOT Analysis
  • 8.12 Shimadzu Corporation
    • 8.12.1 Overview
    • 8.12.2 Product Summary
    • 8.12.3 Financial Performance
    • 8.12.4 SWOT Analysis
  • 8.13 Horiba
    • 8.13.1 Overview
    • 8.13.2 Product Summary
    • 8.13.3 Financial Performance
    • 8.13.4 SWOT Analysis
  • 8.14 Bio- Techne
    • 8.14.1 Overview
    • 8.14.2 Product Summary
    • 8.14.3 Financial Performance
    • 8.14.4 SWOT Analysis
  • 8.15 Charles River Laboratories
    • 8.15.1 Overview
    • 8.15.2 Product Summary
    • 8.15.3 Financial Performance
    • 8.15.4 SWOT Analysis
  • 8.16 Eurofins Scientific
    • 8.16.1 Overview
    • 8.16.2 Product Summary
    • 8.16.3 Financial Performance
    • 8.16.4 SWOT Analysis
  • 8.17 Luminex Corporation
    • 8.17.1 Overview
    • 8.17.2 Product Summary
    • 8.17.3 Financial Performance
    • 8.17.4 SWOT Analysis
  • 8.18 Fluidigm
    • 8.18.1 Overview
    • 8.18.2 Product Summary
    • 8.18.3 Financial Performance
    • 8.18.4 SWOT Analysis
  • 8.19 Abcam
    • 8.19.1 Overview
    • 8.19.2 Product Summary
    • 8.19.3 Financial Performance
    • 8.19.4 SWOT Analysis
  • 8.20 Promega Corporation
    • 8.20.1 Overview
    • 8.20.2 Product Summary
    • 8.20.3 Financial Performance
    • 8.20.4 SWOT Analysis

9 About Us

  • 9.1 About Us
  • 9.2 Research Methodology
  • 9.3 Research Workflow
  • 9.4 Consulting Services
  • 9.5 Our Clients
  • 9.6 Client Testimonials
  • 9.7 Contact Us